|
[1]
|
Chen, B.P., Liang, G., Whelan, J. and Hai, T. (1994) ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. The Journal of Biological Chemistry, 269, 15819-15826.
|
|
[2]
|
Hai, T. and Hartman, M.G. (2001) The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: Activating transcription factor proteins and homeostasis. Gene, 273, 1-11.
http://dx.doi.org/10.1016/S0378-1119(01)00551-0
|
|
[3]
|
Thompson, M.R., Xu, D. and Williams, B.R. (2009) ATF3 transcription factor and its emerging roles in immunity and cancer. Journal of Molecular Medicine, 87, 1053-1060. http://dx.doi.org/10.1007/s00109-009-0520-x
|
|
[4]
|
Hai, T., Wolford, C.C. and Chang, Y.S. (2010) ATF3, a hub of the cellular adaptive-response network, in the pathogenesis of diseases: is modulation of inflammation a unifying component? Gene Expression, 15, 1-11.
http://dx.doi.org/10.3727/105221610X12819686555015
|
|
[5]
|
Liu, B., Agras, K., Willingham, E., Vilela, M.L. and Baskin, L.S. (2006) Activating transcription factor 3 is estrogen-responsive in utero and upregulated during sexual differentiation. Hormone Research, 65, 217-222.
http://dx.doi.org/10.1159/000092402
|
|
[6]
|
Beleza-Meireles, A., Tohonen, V., Soderhall, C., Schwentner, C., Radmayr, C., Kockum, I. and Nordenskjold, A. (2008) Activating transcription factor 3: A hormone responsive gene in the etiology of hypospadias. European Journal of Endocrinology, 158, 729-739.
http://dx.doi.org/10.1530/EJE-07-0793
|
|
[7]
|
Knight, J.C. (2003) Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. Clinical Science, 104, 493-501.
http://dx.doi.org/10.1042/CS20020304
|
|
[8]
|
Knight, J.C. (2005) Regulatory polymorphisms underlying complex disease traits. Journal of Molecular Medicine, 83, 97-109.
http://dx.doi.org/10.1007/s00109-004-0603-7
|
|
[9]
|
Wang, X., Tomso, D.J., Liu, X. and Bell, D.A. (2005) Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicology and Applied Pharmacology, 207, 84-90. http://dx.doi.org/10.1016/j.taap.2004.09.024
|
|
[10]
|
Wang, X., Tomso, D.J., Chorley, B.N., Cho, H.Y., Cheung, V.G., Kleeberger, S.R. and Bell, D.A. (2007) Identification of polymorphic antioxidant response elements in the human genome. Human Molecular Genetics, 16, 1188-1200. http://dx.doi.org/10.1093/hmg/ddm066
|
|
[11]
|
Claessens, F., Verrijdt, G., Schoenmakers, E., Haelens, A., Peeters, B., Verhoeven, G. and Rombauts, W. (2001) Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. The Journal of Steroid Biochemistry and Molecular Biology, 76, 23-30.
http://dx.doi.org/10.1016/S0960-0760(00)00154-0
|
|
[12]
|
Hsu, M.H., Savas, U., Griffin, K.J. and Johnson, E.F. (2007) Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin. The Journal of Biological Chemistry, 282, 5225-5236.
http://dx.doi.org/10.1074/jbc.M608176200
|
|
[13]
|
Takai, H., Araki, S., Mezawa, M., Kim, D.S., Li, X., Yang, L., Li, Z., Wang, Z., Nakayama, Y. and Ogata, Y. (2008) AP1 binding site is another target of FGF2 regulation of bone sialoprotein gene transcription. Gene, 410, 97-104. http://dx.doi.org/10.1016/j.gene.2007.11.017
|
|
[14]
|
Buroker, N.E., Huang, J.Y., Barboza, J., Ledee, D.R., Eastman, R.J., Jr., Reinecke, H., Ning, X.H., Bassuk, J.A. and Portman, M.A. (2012) The adaptor-related protein complex 2, alpha 2 subunit (AP2alpha2) gene is a peroxisome proliferator-activated receptor cardiac target gene. The Protein Journal, 31, 75-83.
http://dx.doi.org/10.1007/s10930-011-9379-0
|
|
[15]
|
Huang, C.N., Huang, S.P., Pao, J.B., Hour, T.C., Chang, T.Y., Lan, Y.H., Lu, T.L., Lee, H.Z., Juang, S.H., Wu, P.P., Huang, C.Y., Hsieh, C.J. and Bao, B.Y. (2012) Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy. Journal of Internal Medicine, 271, 499-509.
http://dx.doi.org/10.1111/j.1365-2796.2011.02449.x
|
|
[16]
|
Huang, C.N., Huang, S.P., Pao, J.B., Chang, T.Y., Lan, Y.H., Lu, T.L., Lee, H.Z., Juang, S.H., Wu, P.P., Pu, Y.S., Hsieh, C.J. and Bao, B.Y. (2012) Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy. Annals of Oncology, 23, 707-713.
http://dx.doi.org/10.1093/annonc/mdr264
|
|
[17]
|
Yu, B., Lin, H., Yang, L., Chen, K., Luo, H., Liu, J., Gao, X., Xia, X. and Huang, Z. (2012) Genetic variation in the Nrf2 promoter associates with defective spermatogenesis in humans. Journal of Molecular Medicine.
|
|
[18]
|
Wu, J., Richards, M.H., Huang, J., Al-Harthi, L., Xu, X., Lin, R., Xie, F., Gibson, A.W., Edberg, J.C. and Kimberly, R.P. (2011) Human FasL gene is a target of betacatenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions. PLoS One, 6, e26143.
http://dx.doi.org/10.1371/journal.pone.0026143
|
|
[19]
|
Alam, M., Pravica, V., Fryer, A.A., Hawkins, C.P. and Hutchinson, I.V. (2005) Novel polymorphism in the promoter region of the human nerve growth-factor gene. International Journal of Immunogenetics, 32, 379-382.
http://dx.doi.org/10.1111/j.1744-313X.2005.00541.x
|
|
[20]
|
Bryne, J.C., Valen, E., Tang, M.H., Marstrand, T., Winther, O., da Piedade, I., Krogh, A., Lenhard, B. and Sandelin, A. (2008) JASPAR, the open access database of transcription factor-binding profiles: New content and tools in the 2008 update. Nucleic Acids Research, 36D, 102-106. http://dx.doi.org/10.1093/nar/gkm955
|
|
[21]
|
Sandelin, A., Alkema, W., Engstrom, P., Wasserman, W.W. and Lenhard, B. (2004) JASPAR: An open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Research, 32D, 91-94.
http://dx.doi.org/10.1093/nar/gkh012
|
|
[22]
|
Sandelin, A., Wasserman, W.W. and Lenhard, B. (2004) ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Research, 32, W249-252.
|
|
[23]
|
Pennisi, E. (2011) The Biology of Genomes. Disease risk links to gene regulation. Science, 332, 1031.
http://dx.doi.org/10.1126/science.332.6033.1031
|
|
[24]
|
Kumar, V., Wijmenga, C. and Withoff, S. (2012) From genome-wide association studies to disease mechanisms: Celiac disease as a model for autoimmune diseases. Seminars in Immunopathology, 34, 567-580.
http://dx.doi.org/10.1007/s00281-012-0312-1
|
|
[25]
|
Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M., Mehta, J.P., Collins, F.S. and Manolio, T.A. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proceedings of the National Academy of Sciences, 106, 9362-9367. http://dx.doi.org/10.1073/pnas.0903103106
|
|
[26]
|
Kumar, V., Westra, H.J., Karjalainen, J., Zhernakova, D.V., Esko, T., Hrdlickova, B., Almeida, R., Zhernakova, A., Reinmaa, E., Vosa, U., Hofker, M.H., Fehrmann, R.S., Fu, J., Withoff, S., Metspalu, A., Franke, L. and Wijmenga, C. (2013) Human disease-associated genetic variation impacts large intergenic non-coding RNA expression. PLoS Genetics, 9, e1003201.
http://dx.doi.org/10.1371/journal.pgen.1003201
|
|
[27]
|
Chorley, B.N., Wang, X., Campbell, M.R., Pittman, G.S., Noureddine, M.A. and Bell, D.A. (2008) Discovery and verification of functional single nucleotide polymerphisms in regulatory genomic regions: current and developing technologies. Mutation Research, 659, 147-157.
http://dx.doi.org/10.1016/j.mrrev.2008.05.001
|
|
[28]
|
Prokunina, L. and Alarcon-Riquelme, M.E. (2004) Regulatory SNPs in complex diseases: Their identification and functional validation. Expert Reviews in Molecular Medicine, 6, 1-15.
http://dx.doi.org/10.1017/S1462399404007690
|
|
[29]
|
Buckland, P.R. (2006) The importance and identification of regulatory polymorphisms and their mechanisms of action. Biochimica et Biophysica Acta, 1762, 17-28.
http://dx.doi.org/10.1016/j.bbadis.2005.10.004
|
|
[30]
|
Sadee, W., Wang, D., Papp, A.C., Pinsonneault, J.K., Smith, R.M., Moyer, R.A. and Johnson, A.D. (2011) Pharmacogenomics of the RNA world: Structural RNA polymorphisms in drug therapy. Clinical Pharmacology & Therapeutics, 89, 355-365.
http://dx.doi.org/10.1038/clpt.2010.314
|